Winckelmann, A., Barton, K., Hiener, B., Schlub, T. E., Shao, W.
, Rasmussen, T. A., Østergaard, L. J., Søgaard, O. S., Tolstrup, M. & Palmer, S. (2017).
Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.
AIDS,
31(6), 771-779.
https://doi.org/10.1097/QAD.0000000000001400
Lausch, K. R., Westh, L.
, Kristensen, L. H., Lindberg, J.
, Tarp, B. & Larsen, C. S. (2017).
Rotavirus is frequent among adults hospitalised for acute gastroenteritis.
Danish Medical Journal,
64(1), Article A5312.
Gane, E. J., Pianko, S., Roberts, S. K., Thompson, A. J., Zeuzem, S., Zuckerman, E., Ben-Ari, Z., Foster, G. R., Agarwal, K.
, Laursen, A. L., Gerstoft, J., Gao, W., Huang, H.-C., Fitzgerald, B., Fernsler, D., Li, J. J., Grandhi, A., Liu, H., Su, F.-H. ... Esteban, R. (2017).
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials.
The Lancet Gastroenterology and Hepatology,
2(11), 805-813.
https://doi.org/10.1016/S2468-1253(17)30159-0Tapia, G.
, Højen, J. F., Ökvist, M.
, Olesen, R., Leth, S., Nissen, S. K., VanBelzen, D. J., O'Doherty, U., Mørk, A., Krogsgaard, K.
, Søgaard, O. S., Østergaard, L., Tolstrup, M., Pantaleo, G. & Sommerfelt, M. A. (2017).
Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs.
The Journal of infection,
75(6), 555-571.
https://doi.org/10.1016/j.jinf.2017.09.004Vibholm, L., Schleimann, M. H., Højen, J. F., Benfield, T.
, Offersen, R., Rasmussen, K., Olesen, R., Dige, A., Agnholt, J., Grau, J., Buzon, M. J., Wittig, B., Lichterfeld, M., Petersen, A. M., Deng, X., Abdel-Mohsen, M., Pillai, S. K., Rutsaert, S., Trypsteen, W.
... Søgaard, O. S. (2017).
Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection.
Clinical Infectious Diseases,
64(12), 1686-1695.
https://doi.org/10.1093/cid/cix201
Dalgard, O., Weiland, O., Noraberg, G., Karlsen, L., Heggelund, L., Färkkilâ, M., Balslev, U., Belard, E., Øvrehus, A., Skalshøi Kjær, M.
, Krarup, H., Thorup Røge, B., Hallager, S., Madsen, L. G.
, Lund Laursen, A., Lagging, M. & Weis, N. (2017).
Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.
PLoS One,
12(7), e0179764. Article e0179764.
https://doi.org/10.1371/journal.pone.0179764Jensen, M. M., Olesen, J. S.
, Jespersen, S., Kjerulff, B., Silva, Z. J. D., Rodrigues, A., Aaby, P.
, Wejse, C., Erikstrup, C. & Hønge, B. L. (2017).
Stabilizing prevalence of HTLV despite decreasing HIV prevalence – 20 years of retroviral surveillance in Guinea-Bissau, West Africa.. Poster session presented at 34th Annual Conference of the Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID), Torshavn, Faroe Islands.
Dalgaard, T., Brock, S., Graversgaard, M., Hansen, B.
, Hashemi, F., Hasler, B., Hertel, O.
, Hutchings, N. J., H.Jacobsen, B., Jensen, L. S.
, Kjeldsen, C., Petersen, J. E., Schjørring, J. K.
, Sigsgaard, T., Andersen, P. S., Termansen, M., Vejre, H.
, Odgaard, M. V., de Vries, W. & Wiborg, I. A. (2017).
Sustainable Nitrogen Management in Denmark.
http://sustainablenconference.dnmark.org/?page_id=298